首页> 外国专利> COMBINATIONS AND COMPOSITIONS THAT INTERFER WITH THE FUNCTION OF VEGF / VEGF RECEIVER AND ANGIOPOYETINA / TIE RECEIVER, AND ITS USE (II).

COMBINATIONS AND COMPOSITIONS THAT INTERFER WITH THE FUNCTION OF VEGF / VEGF RECEIVER AND ANGIOPOYETINA / TIE RECEIVER, AND ITS USE (II).

机译:干扰VEGF / VEGF受体和血管生成素/ TIE受体功能的组合和组成及其用途(II)。

摘要

Pharmaceutical compositions comprising a combination of compound I and compound II, wherein compound I and compound II comprise at least one of (i) a compound of general formula I in which r has the meaning of 0 to 2, n has the meaning of 0 to 2; R3 and R4 a) each, independently of each other, have the meaning of lower alkyl, b) together form a bridge of partial general formula II, where the union takes place via the two terminal atoms C, and m has the meaning of 0 to 4; or c) together form a bridge of partial formula III where one or two of the ring members T1, T2, T3, T4 has the meaning of nitrogen, and each of the remaining has the meaning of CH, and the union takes place via the atoms T1 and T4.
机译:包含化合物I和化合物II的组合的药物组合物,其中化合物I和化合物II包含以下至少一种:(i)通式I的化合物,其中r为0至2的含义,n为0至2的含义。 2; R3和R4 a)彼此独立地具有低级烷基的含义,b)一起形成部分通式II的桥,其中通过两个末端原子C进行结合,并且m的含义为0至4;或c)一起形成部分式III的桥,其中环成员T1,T2,T3,T4中的一个或两个具有氮的含义,其余各环具有CH的含义,并且该结合通过原子T1和T4。

著录项

  • 公开/公告号ES2287152T3

    专利类型

  • 公开/公告日2007-12-16

    原文格式PDF

  • 申请/专利权人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT;

    申请/专利号ES20010965012T

  • 申请日2001-06-20

  • 分类号A61K45/06;C12N15/09;A61K31/517;A61K38;A61K39/395;A61P1/16;A61P9;A61P9/10;A61P13/12;A61P17/06;A61P19/02;A61P27/02;A61P27/06;A61P29;A61P35;A61P43;C07K16/18;C07K16/22;C07K16/28;C12N9/99;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号